Literature DB >> 9727781

Fish consumption and respiratory symptoms among young adults in a Norwegian community.

O Fluge1, E Omenaas, G E Eide, A Gulsvik.   

Abstract

The aim of this study was to investigate the relationship between dietary fish consumption and self-reported respiratory symptoms among young adults. A random sample of 4,300 subjects, aged 20-44 yrs, living in Bergen, Norway, received a postal questionnaire on respiratory symptoms, of whom 80% responded. Mean fish consumption was assessed in a food-frequency questionnaire by asking how often the subject consumed units of fish (150 g) during the last year. Average fish consumption was 1.8 units x week(-1). Fish intake of <1 unit x week(-1) was reported by 24%, 41% reported consumption of 1 unit x week(-1) and 35% intake of >1 unit x week(-1). A high fish intake was significantly associated with increasing age after adjusting for smoking. Adjusted for smoking habits, the prevalence of "cough at night" and "chest tightness" showed a decreasing trend with increasing fish consumption (p<0.05), while such a trend for "wheeze" was demonstrated only in smokers (p=0.008 for interaction). In logistic regression models (adjusting for age, sex, body mass, smoking habits and occupational exposure) fish consumption (three categories) was not significantly associated with "wheeze", "chest tightness", "breathless at night" or "asthma attack", although the odds ratios (OR) were consistently less than 1 (except for "asthma attack"). Fish consumption was of borderline significance as a protective factor of "cough at night", OR = 0.86 (95% confidence interval: 0.76-0.97) but in stratified analyses only in smokers. Subjects reporting very high levels of fish consumption (>14 units x week(-1)) did not have lower prevalences of respiratory symptoms. In conclusion, among young Norwegian adults, with a relatively low prevalence of asthma and an overall high fish intake, fish consumption was not a significant predictor of four out of five respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727781     DOI: 10.1183/09031936.98.12020336

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults.

Authors:  Iris Kompauer; Hans Demmelmair; Berthold Koletzko; Gabriele Bolte; Jakob Linseisen; Joachim Heinrich
Journal:  Eur J Epidemiol       Date:  2008-01-16       Impact factor: 8.082

2.  Occupational allergy and asthma among salt water fish processing workers.

Authors:  Mohamed F Jeebhay; Thomas G Robins; Mary E Miller; Eric Bateman; Marius Smuts; Roslynn Baatjies; Andreas L Lopata
Journal:  Am J Ind Med       Date:  2008-12       Impact factor: 2.214

3.  Severe airway hyperresponsiveness in school-aged boys with a high body mass index.

Authors:  An-Soo Jang; June Huk Lee; Sung Woo Park; Mee Yong Shin; Do Jin Kim; Choon-Sik Park
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

Review 4.  Diet Hypotheses in Light of the Microbiota Revolution: New Perspectives.

Authors:  Tomasz P Wypych; Benjamin J Marsland
Journal:  Nutrients       Date:  2017-05-24       Impact factor: 5.717

Review 5.  Dietary Factors and Risk of Chronic Obstructive Pulmonary Disease: a Systemic Review and Meta-Analysis.

Authors:  Ensiyeh Seyedrezazadeh; Masoud Pour Moghaddam; Khalil Ansarin; Mohammad Asghari Jafarabadi; Akbar Sharifi; Sangita Sharma; Fariba Kolahdooz
Journal:  Tanaffos       Date:  2019-04

6.  Soy consumption and risk of COPD and respiratory symptoms: a case-control study in Japan.

Authors:  Fumi Hirayama; Andy H Lee; Colin W Binns; Yun Zhao; Tetsuo Hiramatsu; Yoshimasa Tanikawa; Koichi Nishimura; Hiroyuki Taniguchi
Journal:  Respir Res       Date:  2009-06-26

Review 7.  Dietary factors in the pathogenesis of asthma and chronic obstructive pulmonary disease.

Authors:  Sarah I Denny; Rachel L Thompson; Barrie M Margetts
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.